Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/88066
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Nursing-
dc.creatorCheng, HL-
dc.creatorLopez, V-
dc.creatorLam, SC-
dc.creatorLeung, AKT-
dc.creatorLi, YC-
dc.creatorWong, KH-
dc.creatorAu, JSK-
dc.creatorSundar, R-
dc.creatorChan, A-
dc.creatorDe Ng, TR-
dc.creatorSuen, LKP-
dc.creatorChan, CW-
dc.creatorYorke, J-
dc.creatorMolassiotis, A-
dc.date.accessioned2020-09-18T02:12:25Z-
dc.date.available2020-09-18T02:12:25Z-
dc.identifier.urihttp://hdl.handle.net/10397/88066-
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.rights© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_US
dc.rightsThe following publication Cheng, H. L., Lopez, V., Lam, S. C., Leung, A. K. T., Li, Y. C., Wong, K. H., . . . Molassiotis, A. (2020). Psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health and Quality of Life Outcomes, 18, 1-9 is available at https://dx.doi.org/10.1186/s12955-020-01493-yen_US
dc.subjectChemotherapyen_US
dc.subjectPeripheral neuropathyen_US
dc.subjectFACTen_US
dc.subjectGOG-Ntxen_US
dc.subjectEORTC QLQ-CIPN20en_US
dc.subjectPsychometricsen_US
dc.subjectResponsivenessen_US
dc.subjectConfirmatory factor analysisen_US
dc.titlePsychometric testing of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapyen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage1-
dc.identifier.epage9-
dc.identifier.volume18-
dc.identifier.doi10.1186/s12955-020-01493-y-
dcterms.abstractBackground The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.-
dcterms.abstractMethods Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID).-
dcterms.abstractResults Cronbach's alpha coefficients of the FACT/GOG-Ntx subscale were 0.82-0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79-0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23-0.45) and motor items (r(s) = 0.15-0.50) as well as the monofilament test (r(s) = 0.23-0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (chi 2/df = 2.26-8.50; allP < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17-0.37). The MCIDs were between 1.38 and 3.68. Conclusion The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationHealth and quality of life outcomes, 2020, v. 18, 246, p. 1-9-
dcterms.isPartOfHealth and quality of life outcomes-
dcterms.issued2020-
dc.identifier.isiWOS:000555940400001-
dc.identifier.pmid32703223-
dc.identifier.eissn1477-7525-
dc.identifier.artn246-
dc.description.validate202009 bcrc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOSen_US
dc.description.pubStatusPublisheden_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Cheng_Psychometric_Testing_Cancer.pdf561.51 kBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

97
Last Week
1
Last month
Citations as of May 12, 2024

Downloads

52
Citations as of May 12, 2024

SCOPUSTM   
Citations

27
Citations as of May 17, 2024

WEB OF SCIENCETM
Citations

24
Citations as of May 16, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.